Cue Biopharma, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Purchase | 30,000 | $1.03 | $30,900 | 164,578 | Dec 16, 2024 |
| Suri Anish | PRESIDENT AND CSO | Purchase | 4,000 | $2.76 | $11,040 | 135,638 | Aug 25, 2023 |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Purchase | 3,000 | $2.86 | $8,580 | 134,578 | Aug 14, 2023 |
| Kiener Peter A | — | Sale | 9,325 | $3.28 | $30,586 | 357 | Mar 23, 2023 |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Tax Withholding | 2,828 | $3.05 | $8,625 | 14,311 | Aug 21, 2022 |
| Gray Cameron | — | Tax Withholding | 51,562 | $3.20 | $164,998 | 687,049 | Jun 14, 2022 |
| Morich Frank | — | Purchase | 28,000 | $3.75 | $105,000 | 28,000 | May 27, 2022 |
| Fletcher Aaron G.L. | — | Purchase | 55,000 | $3.34 | $183,700 | 940,000 | May 23, 2022 |
| Suri Anish | PRESIDENT AND CSO | Option Exercise | 16,668 | — | — | 110,706 | Mar 31, 2022 |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Option Exercise | 75,000 | — | — | 173,700 | Mar 31, 2022 |
| Fletcher Aaron G.L. | — | Purchase | 735,000 | $4.76 | $3,498,600 | 735,000 | Mar 31, 2022 |
| Kiener Peter A | — | Option Exercise | 1,361 | $2.86 | $3,892 | 1,361 | Nov 15, 2021 |
| Suri Anish | President and CSO | Option Exercise | 8,000 | $8.26 | $66,080 | 102,038 | Nov 15, 2021 |
| Suri Anish | President and CSO | Option Exercise | 20,000 | $6.42 | $128,400 | 114,038 | Nov 11, 2021 |
| Suri Anish | PRESIDENT AND CSO | Tax Withholding | 14,134 | $12.97 | $183,318 | 94,038 | Oct 3, 2021 |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Option Exercise | 75,000 | — | — | 130,377 | Sep 30, 2021 |
| PASSERI DANIEL R | CHIEF EXECUTIVE OFFICER | Purchase | 3,400 | $14.72 | $50,048 | 55,377 | Sep 24, 2021 |
| Suri Anish | PRESIDENT AND CSO | Sale | 20,000 | $15.23 | $304,600 | 74,838 | Sep 23, 2021 |
| Millar Kerri-Ann | CHIEF FINANCIAL OFFICER | Sale | 1,251 | $14.21 | $17,777 | 10,472 | Aug 23, 2021 |
| Pienta Kenneth | Chief Medical Officer | Sale | 439 | $15.09 | $6,625 | 2,000 | Mar 15, 2021 |
| Pienta Kenneth | Chief Medical Officer | Option Exercise | 1,280 | $2.86 | $3,661 | 3,280 | Feb 16, 2021 |
| Pienta Kenneth | Chief Medical Officer | Sale | 2,720 | $15.07 | $40,990 | 2,000 | Jan 20, 2021 |
| Pienta Kenneth | Chief Medical Officer | Purchase | 2,720 | $15.07 | $40,990 | 4,720 | Jan 20, 2021 |
| Gray Cameron | — | Gift | 271,000 | — | — | 271,000 | Dec 2, 2020 |
| Fletcher Aaron G.L. | — | Purchase | 6,548 | $12.64 | $82,767 | 165,000 | Nov 24, 2020 |
| Suri Anish | President and CSO | Tax Withholding | 9,800 | $16.30 | $159,740 | 58,091 | Oct 3, 2020 |
| Gray Cameron | — | Purchase | 5,000 | $15.30 | $76,500 | 677,500 | Sep 29, 2020 |
| Millar Kerri-Ann | CFO | Tax Withholding | 1,900 | — | — | 5,766 | Aug 21, 2020 |
| Sandercock Colin | SVP, General Counsel and Sec | Option Exercise | 13,374 | $7.50 | $100,305 | 30,499 | Aug 5, 2020 |
| Sandercock Colin | SVP, General Counsel and Sec | Sale | 13,274 | $20.00 | $265,480 | 17,125 | Aug 5, 2020 |
| Suri Anish | President and CSO | Option Exercise | 800 | $6.42 | $5,136 | 35,358 | Aug 5, 2020 |
| Sandercock Colin | SVP, General Counsel and Sec | Sale | 201 | $20.05 | $4,030 | 17,125 | Aug 3, 2020 |
| Suri Anish | President and CSO | Option Exercise | 400 | $6.42 | $2,568 | 34,958 | Aug 3, 2020 |
| Fletcher Aaron G.L. | — | Purchase | 4,547 | $24.64 | $112,038 | 155,499 | Jun 24, 2020 |
| Suri Anish | President and CSO | Option Exercise | 16,666 | — | — | 39,912 | Mar 31, 2020 |
| MARLETT CHRISTOPHER A | — | Sale | 6,700 | $15.77 | $105,659 | 768,503 | Dec 31, 2019 |
| MARLETT CHRISTOPHER A | — | Sale | 19,647 | $17.53 | $344,412 | 784,203 | Dec 23, 2019 |
| MARLETT CHRISTOPHER A | — | Sale | 20,732 | $15.73 | $326,114 | 824,850 | Dec 19, 2019 |
| Suri Anish | President and CSO | Option Exercise | 33,333 | — | — | 35,333 | Nov 1, 2019 |
| PASSERI DANIEL R | CEO and President | Purchase | 1,377 | $7.26 | $9,997 | 51,977 | Jun 21, 2019 |
| Sandercock Colin | SVP, General Counsel and Sec | Purchase | 15,025 | $7.90 | $118,698 | 17,125 | Jun 7, 2019 |
| Sandercock Colin | SVP, General Counsel and Sec | Purchase | 14,938 | $7.93 | $118,458 | 16,938 | Jun 6, 2019 |
| PASSERI DANIEL R | CEO and President | Purchase | 3,000 | $6.90 | $20,700 | 50,600 | Jun 6, 2019 |
| MARLETT CHRISTOPHER A | — | Purchase | 18,521 | $4.64 | $85,937 | 89,602 | Dec 31, 2018 |
| DIGIANDOMENICO ANTHONY | — | Purchase | 7,000 | $4.62 | $32,340 | 57,000 | Dec 28, 2018 |
| DIGIANDOMENICO ANTHONY | — | Purchase | 20,000 | $4.77 | $95,400 | 50,000 | Dec 27, 2018 |
| MARLETT CHRISTOPHER A | — | Purchase | 19,647 | $4.29 | $84,286 | 71,081 | Dec 26, 2018 |
| DIGIANDOMENICO ANTHONY | — | Purchase | 10,000 | $4.81 | $48,100 | 30,000 | Dec 24, 2018 |
| Suri Anish | Chief Scientific Officer | Purchase | 2,000 | $4.37 | $8,740 | 2,000 | Dec 21, 2018 |
| MARLETT CHRISTOPHER A | — | Purchase | 17,200 | $4.53 | $77,916 | 51,434 | Dec 21, 2018 |